enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Why Ionis Pharmaceuticals (IONS) Might Surprise This ... - AOL

   www.aol.com/news/why-ionis-pharmaceuticals-ions...

   Ionis Pharmaceuticals (IONS) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

3. Ionis (IONS) Q3 Earnings & Sales Beat Estimates, Stock Up - AOL

   www.aol.com/news/ionis-ions-q3-earnings-sales...

   For premium support please call: 800-290-4726 more ways to reach us

4. Ionis (IONS) Q2 Loss Narrower Than Expected, Revenues Miss - AOL

   www.aol.com/news/ionis-ions-q2-loss-narrower...

   For premium support please call: 800-290-4726 more ways to reach us

5. Ionis (IONS) Q3 Earnings & Revenues Fall Short of Estimates - AOL

   www.aol.com/news/ionis-ions-q3-earnings-revenues...

   Ionis (IONS) incurs wider-than-expected Q3 loss. The company maintains its top-and bottom-line guidance for 2021 Ionis (IONS) Q3 Earnings & Revenues Fall Short of Estimates

6. Ionis Pharmaceuticals - Wikipedia

   en.wikipedia.org/wiki/Ionis_Pharmaceuticals

   Ionis Pharmaceuticals, Inc. is a biotechnology company based in Carlsbad, California, that specializes in discovering and developing RNA-targeted therapeutics.The company has three commercially approved medicines: Spinraza (), Tegsedi (), and Waylivra (Volanesorsen), and has four drugs in pivotal studies: tominersen for Huntington's disease (together with Roche), tofersen for SOD1-ALS, AKCEA ...

7. Ion Group - Wikipedia

   en.wikipedia.org/wiki/ION_Group

   Ion Group (also known as Ion and Ion Investment Group) is a financial data and software company headquartered in London. The company has expanded rapidly through a series of acquisitions . The Financial Times has compared it to Bloomberg L.P although it has a low profile.

8. Ionis Pharmaceuticals (IONS) Reports Q2 Loss, Lags ... - AOL

   www.aol.com/news/ionis-pharmaceuticals-ions...

   Ionis Pharmaceuticals (IONS) delivered earnings and revenue surprises of -1.79% and -9.17%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

9. Acuris - Wikipedia

   en.wikipedia.org/wiki/Acuris

   Acuris is a British financial news and data firm known for its fixed income research provider Debtwire and Mergermarket, a specialist in M&A intelligence. It is owned by ION Investment Group, a financial software and data business which owns Fidessa and Dealogic.